#cancer research

A look at the scientists behind David Julius’s Nobel Prize for discoveries regarding the proteins that help us sense temperature and pain.

Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.

A discovery in how cells absorb substances provides insights into certain cancers and may be applied to therapeutic drugs.

About 1 in 1,000 pregnant women is diagnosed with cancer. Do newer treatments, such as immunotherapy, work in this group of patients?

Humans and companion animals get similar cancers, so clinical trials in dogs can lead to research in humans—and vice versa.

New insights on the link between colorectal cancer risk and BHB, a compound produced from ketogenic diets.

A new study clarifies the benefits and risks of treatments for those with multiple myeloma, a blood cancer more common in Black Americans.

Study findings suggest that medicinal cannabis can be considered as an alternative to opiate painkillers prescribed to people with cancer.

Known as a carbon nanotube, the implant can detect cancer-associated proteins and alert a devise outside the body.

Imagine a blood test that could detect multiple types of early stage cancer. As they’re being developed, questions and concerns arise.

“While this approach is not restricted to analyzing tumor tissues, there are obvious applications for better understanding cancer."

CU Cancer Center member Janet Kukreja, MD, talks diagnosis, treatment, and causes as Bladder Cancer Awareness Month begins.

Embryos in the womb can get gene mutations that lead to cancer in adulthood.

The new collaboration aims to enable cancer researchers to learn from every patient by actively engaging them in clinical research.

Researchers hope to easily identify which colon cancer patients are unlikely to benefit from immune checkpoint inhibitors (ICIs).

Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.